Table 5. Characteristics of the 190 trials registered with one of the 72 drugs of the ReDO_DB tested in clinical trials.
N | % | ||
---|---|---|---|
Drug with more than 10 trials | |||
Acetylsalicylic acid | 27 | 14 | |
Celecoxib | 12 | 6 | |
Cholecalciferol | 12 | 6 | |
Metformin | 17 | 9 | |
Olanzapine | 10 | 5 | |
Zoledronic Acid | 20 | 11 | |
Cancer Type | |||
Gastrointestinal | 53 | 28 | |
Breast | 38 | 20 | |
Hematologic | 23 | 12 | |
Lung | 14 | 7 | |
Gynaecologic | 11 | 6 | |
Brain and CNS | 10 | 5 | |
Other | 24 | 13 | |
Paediatric | 12 | 6 | |
Not specified | 23 | 12 | |
Trial Location | |||
Europe | 68 | 36 | |
Asia | 61 | 32 | |
North America | 48 | 25 | |
Middle East | 11 | 6 | |
Oceania | 7 | 4 | |
South & Central America | 6 | 3 | |
Africa | 5 | 3 | |
Sponsor | |||
University and/or hospital | 127 | 67 | |
Research Institute, organisation, foundation or network | 53 | 28 | |
Small- and medium-sized pharmaceutical companies | 6 | 3 | |
Government | 3 | 2 | |
Large pharmaceutical companies | 1 | 1 |